PAVmed Inc. (PAVM): Prakiraan wutah bathi saben saham kanggo taun ngarep

PAVmed Inc. revenues are growing through the commercialization of EsoGuard tests. The company is expanding its influence via clinic partnerships and patent acquisitions. The expected earnings per share growth rate in the GURU.Markets system reflects a trend where the indicator remains around 45.50. Its status as a diversified incubator and its unique esophageal cancer screening provide the issuer with complete pricing power.

PAVmed Inc. (PAVM): Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan PAVmed Inc.

- rega lan prakiraan konsensus rega:

Bagan rega PAVmed, Inc.|PAVM - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Biji pasar PAVmed|PAVM - Nilai Perusahaan

- informasi kapitalisasi buku:

Aset Bersih saben Siji Saham PAVmed|PAVM - Pambiji Buku Bisnis|Rasio Kapitalisasi marang Aset Bersih pavmed.com|PAVM - Nilai Agregat Aset

- rincian utang lan likuiditas:

- data bathi resik lan rasio valuasi:

PAVM - Penghasilan resik|Proyeksi bathi mangsa ngarep PAVmed Inc.|PAVM - Pangali P/E|Rega marang bathi mangsa ngarep PAVmed, Inc.|PAVM - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan PAVmed|PAVM - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) PAVmed|PAVM - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan pavmed.com|PAVM - Owah-owahan bathi resik saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep PAVmed Inc.

- rincian pendapatan lan dodolan:

PAVM - Pendapatan lan volume dodolan|Prakiraan volume dodolan PAVmed, Inc.|PAVM - Koefisien rega marang pendapatan|Rasio rega marang prakiraan pendapatan PAVmed

Analisis fundamental perusahaan:PAVmed Inc., PAVM

This indicator measures the expected percentage growth in earnings per share, reflecting the analysts' consensus forecast regarding the future profitability of the business. Given the stable supply chains and ethical safeguards of PAVmed Inc. medical developments, this chart of analyst EPS growth estimates serves as a tool for assessing the company's strategic potential, allowing investors to optimize their portfolios in a timely manner based on fundamental trends.

Perusahaan pesaing